On January 20, 2026, Arturo Molina, Chief Medical Officer of Protagonist Therapeutics (NASDAQ: PTGX), executed a direct market sale of 9,514 shares, generating proceeds of approximately $784,700. This transaction offers a rare window into insider confidence and strategic positioning at a biotech